NON HODGKIN LYMPHOMA (NHL)

Clinical trials for NON HODGKIN LYMPHOMA (NHL) explained in plain language.

Never miss a new study

Get alerted when new NON HODGKIN LYMPHOMA (NHL) trials appear

Sign up with your email to follow new studies for NON HODGKIN LYMPHOMA (NHL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet recruiting 1 Not yet finished but already full! 2 Completed 1 Terminated 1

Ready-Made immune cells take on blood cancers in early trial

Disease control Not yet recruiting

This early-phase study tests a new cell therapy called ALA-101 for people with CD19+ non-Hodgkin lymphoma or leukemia. The therapy uses donor immune cells that are specially designed to find and attack cancer cells. The main goals are to check safety and find the best dose, with …

Matched conditions: NON HODGKIN LYMPHOMA (NHL)

Phase: PHASE1 • Sponsor: Arovella Therapeutics Ltd • Aim: Disease control

Last updated Jun 27, 2026 12:05 UTC

NON HODGKIN LYMPHOMA (NHL)

Get alerted when new NON HODGKIN LYMPHOMA (NHL) trials appear

Ready-Made immune cells take on blood cancers in early trial